09:54 AM EST - Fennec Pharmaceuticals Inc. : Reported its financial results for the first quarter ended March 31, 2020. Net loss for the quarter ended March 31, 2020 was $3.8 million ($0.19 per share), compared to $2.6 million ($0.13 per share) for the same period in 2019. Fennec Pharmaceuticals Inc.
shares T.FRX are trading unchanged at $9.88.
